Rapamycin: Drug Repurposing in SARS-CoV-2 Infection

Rapamycin: Drug Repurposing in SARS-CoV-2 Infection

Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectivene...

Full description

Bibliographic Details
Main Authors:	Jiri Patocka, Kamil Kuca, Patrik Oleksak, Eugenie Nepovimova, Martin Valis, Michal Novotny, Blanka Klimova
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Pharmaceuticals
Subjects:	COVID-19 SARS-CoV-19 rapamycin sirolimus mTOR inhibitor
Online Access:	https://www.mdpi.com/1424-8247/14/3/217

Similar Items

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
by: Krzysztof Sadowski, et al.
Published: (2022-04-01)

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
by: Zofia Chrienova, et al.
Published: (2022-12-01)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
by: Wei Zhao, et al.
Published: (2023-06-01)

mTOR Pathway Substrates Present High Activation in Vascular Malformations and Significantly Decrease with Age
by: Jakub Kopeć, et al.
Published: (2023-12-01)

Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot Study
by: Victor N. Rivas, et al.
Published: (2023-10-01)

Does Lymphovenous Anastomosis Effect Mammalian Target of Rapamycin Inhibitor-associated Lymphedema Patients?
by: Inah Yoon, et al.

Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis
by: Yu-Ting Lin, et al.
Published: (2022-03-01)

mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
by: Hakim Bouamar, et al.
Published: (2023-10-01)

Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas
by: Elise F. Nassif, et al.
Published: (2023-02-01)

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
by: Cabrera-López Cristina, et al.
Published: (2012-11-01)

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022-07-01)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
by: Wang Cun, et al.
Published: (2012-05-01)

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
by: Delphine Séhédic, et al.
Published: (2021-02-01)

A pulse rapamycin therapy for infantile spasms and associated cognitive decline
by: Emmanuel Raffo, et al.
Published: (2011-08-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Therapeutic Effect of Rapamycin on Aortic Dissection in Mice
by: Makiko Hayashi-Hori, et al.
Published: (2020-05-01)

Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer
by: Belinda Seto
Published: (2012-12-01)

Progress in the Treatment of Topical Rapamycin Preparations
by: WANG Senfen, et al.
Published: (2023-04-01)

Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults
by: Romain Gabeff, et al.
Published: (2019-09-01)

Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
by: Minghao Li, et al.
Published: (2022-03-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage
by: Jie-Ping Wang, et al.
Published: (2017-01-01)

Rapamycin Rescues the Poor Developmental Capacity of Aged Porcine Oocytes
by: Seung Eun Lee, et al.
Published: (2014-05-01)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
by: Jing eJiang, et al.
Published: (2013-08-01)

Lymphangioleiomyomatosis associated with prolactinoma: A case report and literature review
by: Yosuke Murakami, et al.
Published: (2021-01-01)

Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021-05-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus
by: Murilo Batista Abud, et al.
Published: (2019-09-01)

Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
by: Antonella Tramutola, et al.
Published: (2018-11-01)

The effects of AICAR and rapamycin on mitochondrial function in immortalized mitochondrial DNA mutator murine embryonic fibroblasts
by: Vedad Delic, et al.
Published: (2018-11-01)

Effects of Monensin and Rapamycin Combination Therapy on Tumor Growth and Apoptosis in a Xenograft Mouse Model of Neuroblastoma
by: Sema Serter Kocoglu, et al.
Published: (2023-06-01)

Neuropharmacology of Cevimeline and Muscarinic Drugs—Focus on Cognition and Neurodegeneration
by: Patrik Oleksak, et al.
Published: (2021-08-01)

Active Mechanistic Target of Rapamycin plays an ancillary rather than essential role in Zebrafish CNS axon regeneration
by: Heike eDiekmann, et al.
Published: (2015-07-01)

Rapamycin improves the quality and developmental competence of mice oocytes by promoting DNA damage repair during in vitro maturation
by: Qiyu Yang, et al.
Published: (2022-04-01)

Isolated Components From Spider Venom Targeting Human Glioblastoma Cells and Its Potential Combined Therapy With Rapamycin
by: Marcus Caballero, et al.
Published: (2022-03-01)

mTOR inhibition: a promise for a young heart.
by: Stêfany Bruno De Assis Cau, et al.
Published: (2012-02-01)

A New Hypothesis Describing the Pathogenesis of Oral Mucosal Injury Associated with the Mammalian Target of Rapamycin (mTOR) Inhibitors
by: Stephen T. Sonis, et al.
Published: (2023-12-01)

Single-Dose Treatment with Rapamycin Preserves Post-Ischemic Cardiac Function through Attenuation of Fibrosis and Inflammation in Diabetic Rabbit
by: Arun Samidurai, et al.
Published: (2023-05-01)

Acute rapamycin rescues the hyperexcitable phenotype of accumbal medium spiny neurons in the valproic acid rat model of autism spectrum disorder
by: D. Iezzi, et al.
Published: (2022-09-01)

mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?
by: E. Scott Sills, et al.
Published: (2023-07-01)